Physician profile
James S Otoshi
NPI 1679681027
$1,556.85
in general payments reported to CMS, 2019-2025
20 companies · $68.73 in 2025
The $68.73 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $296 · 2021: $158 · 2022: $35.00 · 2023: $74.36 · 2024: $178 · 2025: $68.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.80 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $279.06 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.85 | 2019-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $224.78 | 2019-2024 | Airsupra |
| Mylan Specialty L.P. | $114.64 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $100.59 | 2019-2020 | |
| Insmed, INC. | $88.01 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $85.89 | 2019-2020 | |
| Genzyme Corporation | $57.34 | 2019 | |
| Philips North America LLC | $51.21 | 2019 | |
| Intuitive Surgical, INC. | $46.61 | 2023 | Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $36.23 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $32.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.34 | 2019 | |
| Electromed, INC. | $23.63 | 2019 | |
| Advanced Respiratory, INC | $20.53 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $19.28 | 2021 | |
| Resmed Corp | $19.21 | 2019 | |
| Pulmonx Corporation | $18.97 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.95 | 2019 | |
| Lilly USA, LLC | $16.74 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Otoshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.